Biotechnology

The UK biotech sector has fallen victim to the mayhem in the capital markets. After a year of falling share prices, five quoted companies have put up “for sale” signs.

Corporate incubators bridge the seed funding gap, but apart from pocket money what can start-ups learn from their foster parents?

Follow the fashion: the biotech financing model has changed. But will today’s start-ups be tomorrow’s fashion victims?

Today France Biotech celebrates its tenth birthday at the Eurobio Show in Lille. And the picture has never been rosier.

Nordforsk, the funding agency of the Nordic Council of Ministers, has funded the coordination of a network on biomedical imaging.

After a decade of withering in the shade of genetically modified crops, plant sciences are back on the political agenda in Europe follow the launch this week of a new Strategic Research Agenda.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.